Demographic Considerations in Tacrolimus Pharmacokinetics
- 1 June 1998
- journal article
- Published by Elsevier in Transplantation Proceedings
- Vol. 30 (4) , 1359-1364
- https://doi.org/10.1016/s0041-1345(98)00275-9
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Pharmacokinetic-pharmacodynamic relationships of controlled-release oxycodone*Clinical Pharmacology & Therapeutics, 1996
- Effect of age and gender on tirilazad pharmacokinetics in humansClinical Pharmacology & Therapeutics, 1994
- TacrolimusDrugs, 1993
- Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantationClinical Pharmacology & Therapeutics, 1993
- Demographic factors influencing cyclosporine pharmacokinetic parameters in patients with uremia: Racial differences in bioavailabilityClinical Pharmacology & Therapeutics, 1992
- Effect of age and gender on the activity of human hepatic CYP3ABiochemical Pharmacology, 1992
- DEMOGRAPHIC FACTORS AFFECTING THE PHARMACOKINETICS OF CYCLOSPORINE ESTIMATED BY RADIOIMMUNOASSAYTransplantation, 1986
- Sex-Related Differences in Drug Disposition in ManClinical Pharmacokinetics, 1984
- Cytochrome P-450 as a determinant of sex difference of drug metabolism in the ratXenobiotica, 1982
- Sex-Related Differences in Drug MetabolismDrug Metabolism Reviews, 1975